CRSP we might consolidate now to cut through 60 and to pock 61-62 in power hour. small caps and arkk are feeling better than spy. we can keep squeezing higher and overextend, i'd like to re-test 55 soon
CRSP These results have raised excitement around CTX320, a readout from which is expected later in the second quarter of 2025. CRISPR Therapeutics also intends to advance two additional in vivo programs into the clinic by year-end, further expanding its footprint in this emerging modality. Last month, CRSP reported initial top-line data from the first 10 patients across the first four cohorts of the phase I study on CTX310. A single dose demonstrated dose-dependent decreases in low-density lipoprotein (LDL) and triglyceride (TG) levels, with peak reduction of up to 82% in TG and up to 81% in LDL. However, Competitors here and near to approve they product by FDA! Might have negative impact on CRSP prices!
CRSP so time to buy ..."If you're talking about siRNA, that is $30,000 a year for 50 years," said Crispr Therapeutics Chief Executive Samarth Kulkarni at an April conference. "We could spend one-tenth of that and charge $150,000 for a single-shot therapy. For the payer, the economic argument is very clear."
CRSP seems like a nice long-term hold tradingview.com/x/UNFpAAgn/
